{"id":"W4378953442","doi":"10.3324/haematol.2023.283106","title":"Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech; Italfarmaco; Astellas Pharma; Sierra Oncology; CTI Biopharma; Incyte; Jazz Pharmaceuticals; Gilead Sciences; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Internal medicine; Oncology; Bone marrow","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007043305,0.0001207208,0.0004363758,0.0003112505,0.0005465134,0.0006877315,0.0003552918,0.001641129,0.002682057],"category_scores_gemma":[0.00527776,0.00008841541,0.0003537486,0.0008433376,0.0002749363,0.0004591514,0.000239913,0.001171167,0.0009042504],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001283902,"about_ca_system_score_gemma":0.0007375379,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003200657,"about_ca_topic_score_gemma":0.006187871,"domain_scores_codex":[0.9993586,0.000187094,0.00007254771,0.0000683697,0.0001432624,0.0001700676],"domain_scores_gemma":[0.9972181,0.001148905,0.0005043945,0.00008982312,0.0004355114,0.0006032012],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007503169,0.0004481693,0.585239,0.0003228931,0.0002552977,0.06481975,0.0004876103,0.00131571,0.002322409,0.00208026,0.1909022,0.1443035],"study_design_scores_gemma":[0.001162206,0.001943153,0.7995567,0.0007969417,0.0003082573,0.08518253,0.001729954,0.002237227,0.001060305,0.008186023,0.09769054,0.0001461304],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"editorial","genre_scores_codex":[0.6272712,0.02258342,0.0004940942,0.2621693,0.003464044,0.0001053548,0.006715798,0.00008078514,0.07711598],"genre_scores_gemma":[0.9535268,0.003555725,0.0002413337,0.03286305,0.002693451,0.00006344531,0.002002008,0.00001319212,0.0050409],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.003200657,"threshold_uncertainty_score":0.009315372,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02960954829240236,"score_gpt":0.2987874401481742,"score_spread":0.2691778918557718,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}